Philip Stevens, Executive Director, Geneva Network. The European Parliament in April voted through a proposal that will allow generic companies to manufacture and export outside the EU copies of medicines that are still essentially patent protected in Europe. This vote around what’s known as the Supplementary Protection Certificate (SPC) Export Waiver may […]
Tag: health care
DELINKAGE: CAN PRIZES REPLACE PATENTS FOR MEDICINE INNOVATION?
By Philip Stevens, Executive Director, Geneva Network Republished with permission of the Geneva Network. Original available here. The patent-based system of drug development comes under further pressure from key countries aiming to increase access to medicines at a joint World Health Organization and Government of India meeting in New Delhi this week. […]